Tubulis’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Tubulis is a biotechnology company that develops antibody-drug conjugates for the treatment of cancer. Read more

Tubulis is a biotechnology company that develops antibody-drug conjugates for the treatment of cancer. Read more

Dominik Schumacher's photo - Co-Founder & CEO of Tubulis

Co-Founder & CEO

Dominik Schumacher

CEO Approval Rating

90/100

Founded:

2016

Status:

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Glycotope is Tubulis's #1 competitor. Glycotope's headquarters is in Berlin, Berlin, and was founded in 2000. Like Tubulis, Glycotope also works within the Biotechnology sector. Glycotope generates ∞% of Tubulis's revenue.

NBE-Therapeutics is one of Tubulis's top rivals. NBE-Therapeutics was founded in Basel, Basel-Country} in 2012. NBE-Therapeutics competes in the Health Care Services industry. Compared to Tubulis, NBE-Therapeutics generates $5M more revenue.

OBT is one of Tubulis's top competitors. OBT is a Private company that was founded in 2003 in Abingdon, England. OBT operates in the Biotechnology industry. Compared to Tubulis, OBT has 21 more employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 9 a good estimate for Tubulis's Employee count?

Acquisitions

No recent acquisitions found related to Tubulis

Tubulis Funding History

$0$12.2M

Since Tubulis was founded in 2016, it has participated in 2 rounds of funding. In total Tubulis has raised $12.2M. Tubulis' last funding round was on Jul 2020 for a total of $12.2M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jul 2020
$12.2M

BioMedPartners

Grant
Dec 2017
--
-

Total Funding: $12.2M

Since Tubulis was founded in 2016, it has participated in 2 rounds of funding. In total Tubulis has raised $12.2M. Tubulis' last funding round was on Jul 2020 for a total of $12.2M

Investments

No recent investments found related to Tubulis

Tubulis News

Headquarters

Butenandtstrabe 1

Munich, Bavaria81377

49-89-218071081

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Tubulis is a biotechnology company that develops antibody-drug conjugates for the treatment of cancer. Tubulis was founded in 2016. Tubulis' headquarters is located in Munich, Bavaria, DE 81377. It has raised 12.2M in 2 rounds. The latest round was in...

CEO

Tubulis's Co-Founder & CEO, Dominik Schumacher, currently has an approval rating of 90%. Tubulis's primary competitors are Glycotope, NBE-Therapeutics & OBT.

Website

tubulis.com

Frequently Asked Questions about Tubulis

  1. When was Tubulis founded?

    Tubulis was founded in 2016
  2. Who is Tubulis's CEO?

    Tubulis's CEO is Dominik Schumacher
  3. How much revenue does Tubulis generate?

    Tubulis generates $ < 1M in revenue
  4. How much funding does Tubulis have?

    Tubulis has historically raised $12.2M in funding
  1. Where is Tubulis's headquarters?

    Tubulis's headquarters is in Munich Bavaria, DE
  2. How many employees does Tubulis have?

    Tubulis has 9 employees
  3. What sector does Tubulis operate in?

    Tubulis is in Biotechnology
  4. Who are Tubulis's competitors?

    Tubulis's top competitors are Glycotope, NBE-Therapeutics, OBT